Patents by Inventor Bindhu Madhavi Rayaprolu

Bindhu Madhavi Rayaprolu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230084291
    Abstract: Injectable iron compositions comprising iron, a carbohydrate, a stabilizing agent and water are provided. These iron compositions can be prepared by mixing iron with a carbohydrate and water to form a mixture and adding a stabilizing agent to the mixture to form the stable injectable iron composition. These compositions can be considered “ready-to-use” and can treat a variety of diseases, disorders, or conditions characterized by iron deficiency or dysfunctional iron metabolism, for example, anemia.
    Type: Application
    Filed: August 25, 2022
    Publication date: March 16, 2023
    Applicant: American Regent, Inc.
    Inventors: Roshan James, Bindhu Madhavi Rayaprolu, Ting Zhang, Meng Zhong
  • Publication number: 20220016097
    Abstract: Provided herein are pharmaceutical compositions comprising a class of calcium channel blockers and at least one chelating agent. More specifically, the pharmaceutical compositions comprise at least one 1,4-dihydropyridine (DHP) compound and at least one chelating agent. The chelating agents used in this disclosure can decrease the degradation of the constituent DHPs of the DHP compositions. The DHP compositions can be used to treat cardiovascular disorders and are more stable for prolonged periods of time.
    Type: Application
    Filed: October 1, 2021
    Publication date: January 20, 2022
    Applicant: American Regent, Inc.
    Inventors: Daniel Walter Wehrung, Meng Zhong, Saral Pinkal Patel, Bindhu Madhavi Rayaprolu
  • Patent number: 11135208
    Abstract: Provided herein are pharmaceutical compositions comprising a class of calcium channel blockers and at least one chelating agent. More specifically, the pharmaceutical compositions comprise at least one 1,4-dihydropyridine (DHP) compound and at least one chelating agent. The chelating agents used in this disclosure can decrease the degradation of the constituent DHPs of the DHP compositions. The DHP compositions can be used to treat cardiovascular disorders and are more stable for prolonged periods of time.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: October 5, 2021
    Assignee: American Regent, Inc.
    Inventors: Daniel Walter Wehrung, Meng Zhong, Saral Pinkal Patel, Bindhu Madhavi Rayaprolu
  • Publication number: 20210046062
    Abstract: Provided herein are pharmaceutical compositions comprising a class of calcium channel blockers and at least one chelating agent. More specifically, the pharmaceutical compositions comprise at least one 1,4-dihydropyridine (DHP) compound and at least one chelating agent. The chelating agents used in this disclosure can decrease the degradation of the constituent DHPs of the DHP compositions. The DHP compositions can be used to treat cardiovascular disorders and are more stable for prolonged periods of time.
    Type: Application
    Filed: March 11, 2020
    Publication date: February 18, 2021
    Inventors: Daniel Walter Wehring, Meng Zhong, Saral Pinkal Patel, Bindhu Madhavi Rayaprolu